Skip to content
Home/Companies/Pharma/DOC Generici (ICG)

DOC Generici (ICG)

Pharma·Italy·Exited 2022·Held 3yr
Entry
2019
Hold
3yr
Exit
2022

Who owns DOC Generici (ICG)?

DOC Generici (ICG) was owned by ICG through ICG Europe Fund VII (2018 vintage) from 2019 to 2022, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-30

ICG
Investor
ICG
ICG Europe Fund VII · 2018 · Mezzanine

Key facts

HQItaly
SectorPharma
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2022

More from ICG Europe Fund VII

Other portfolio companies in the same fund.

Circet
Circet
Active
Business ServicesFrance· 2021
Grupo Konecta
Active
Business ServicesSpain· 2019
Minimax Viking
Minimax Viking
Exited 2025
ConstructionGermany· 2018
to
Nadella
Active
IndustrialsItaly· 2018

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track DOC Generici (ICG)

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy DOC Generici (ICG)?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on DOC Generici (ICG).

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue